Ann Elizabeth Tollefson

Dr. Ann Elizabeth Tollefson


Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 September 2022 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
SGShenghua Gao
Shenghua Gao
KSKatharina Sylvester
Katharina Sylvester
LSLetian Song
Letian Song
TCTobias Claff
Tobias Claff
LJLanlan Jing
Lanlan Jing
Peng ZhanPeng Zhan
Peng Zhan

7 December 2022 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
SGShenghua Gao
Shenghua Gao
LSLetian Song
Letian Song
TCTobias Claff
Tobias Claff
MWMolly Woodson
Molly Woodson
KSKatharina Sylvester
Katharina Sylvester
XLXinyong Liu
Xinyong Liu

6 May 2018 in Viruses
Verified
Journal Article
Open access
PDF file
JMJinxin Miao
Jinxin Miao
BYBaoling Ying
Baoling Ying
RLRong Li
Rong Li
ATAnn Elizabeth Tollefson
Ann Elizabeth Tollefson
JSJacqueline F. Spencer
Jacqueline F. Spencer
Zhongde WangZhongde Wang
Zhongde Wang
The accumulating evidence demonstrates that Syrian hamsters have advantages as models for various diseases. To develop a Syrian hamster (Mesocricetus auratus) model of human immunodeficiency caused by RAG1 gene mutations, we employed the CRISPR/Cas9 system and introduced an 86-nucleotide frameshift deletion in the hamster RAG1 gene encoding part of the N-terminal non-core domain of RAG1. Histological and immunohistochemical analyses demonstrated that these hamsters (referred herein as RAG1-86nt hamsters) had atrophic spleen and thymus, and developed significantly less white pulp and were almost completely devoid of splenic lymphoid follicles. The RAG1-nt86 hamsters had barely detectable CD3+ and CD4+ T cells. The expression of B and T lymphocyte-specific genes (CD3γ and CD4 for T cell-specific) and (CD22 and FCMR for B cell-specific) was dramatically reduced, whereas the expression of macrophage-specific (CD68) and natural killer (NK) cell-specific (CD94 and KLRG1) marker genes was increased in the spleen of RAG1-nt86 hamsters compared to wildtype hamsters. Interestingly, despite the impaired development of B and T lymphocytes, the RAG1-86nt hamsters still developed neutralizing antibodies against human adenovirus type C6 (HAdV-C6) upon intranasal infection and were capable of clearing the infectious viruses, albeit with slower kinetics. Therefore, the RAG1-86nt hamster reported herein (similar to the hypomorphic RAG1 mutations in humans that cause Omenn syndrome), may provide a useful model for studying the pathogenesis of the specific RAG1-mutation-induced human immunodeficiency, the host immune response to adenovirus infection and other pathogens as well as for evaluation of cell and gene therapies for treatment of this subset of RAG1 mutation patients.

24 July 2002 in Cancer Gene Therapy
Verified
Journal Article
Closed access
PDF file
NHNagy Habib
Nagy Habib
RMRagai Mitry
Ragai Mitry
PSPrem Seth
Prem Seth
MKMohan Kuppuswamy
Mohan Kuppuswamy
KDKonstantin Doronin
Konstantin Doronin
WWWilliam S M Wold
William S M Wold

17 August 2023 in RSC Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
XJXiangyi Jiang
Xiangyi Jiang
JLJing Li
Jing Li
AVAntonio Viayna
Antonio Viayna
FLF. Javier Luque
F. Javier Luque
MWMolly Woodson
Molly Woodson
Peng ZhanPeng Zhan
Peng Zhan
SARS-CoV-2 3-chymotrypsin-like protease (3CL pro ) is considered an attractive target for the development of anti-COVID-19 agents due to its vital function.

6 January 2024 in Antiviral Research
Verified
Journal Article
Closed access
ATAnn Elizabeth Tollefson
Ann Elizabeth Tollefson
SRSamantha B. Riemann
Samantha B. Riemann
BYBaoling Ying
Baoling Ying
JSJacqueline F. Spencer
Jacqueline F. Spencer
JOJustin M. Overhulse
Justin M. Overhulse
KTKaroly Toth
Karoly Toth